Online
Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
AstraZeneca takes Lupin to NJ court over Nexium
AstraZeneca has taken Lupin to New Jersey Court over Nexium—the company’s anti-ulcer blockbuster, claiming non-infringement on 5 Nexium. In an intervi...
09-11-2009
Ranbaxy Labs
Ranbaxy Labs an underperformer: Karvy
Ranbaxy Laboratories is an underperformer, says Karvy Stock Broking's research report. ...
06-10-2009
11-09-2009: Motilal Oswal neutral on Ranbaxy Labs
31-08-2009: Sell Ranbaxy, target of Rs 225: IIFL
29-07-2009: Sell Ranbaxy Labs, target of Rs 212: Reliance Money
27-07-2009: Sell Ranbaxy Laboratories: IIFL
AstraZeneca takes Lupin to NJ court over Nexium
AstraZeneca has taken Lupin to New Jersey Court over Nexium—the company’s anti-ulcer blockbuster, claiming non-infringement on 5 Nexium. In an intervi...
09-11-2009
07-11-2009: Dr Reddy's files for marketing Lipitor generic
06-11-2009: Sun Pharma underperformer, target Rs 1355: Karvy
06-11-2009: Sun Pharma gets US nod for generic Acular
06-11-2009: Buy Cipla, says Sudarshan Sukhani
Peers
Sun Pharma underperformer, target Rs 1355: Karvy
Karvy Stock Broking has recommended an underperformer rating on Sun Pharmaceuticals, with price target of Rs 1355, in its report dated November 6, 200...
06-11-2009
04-11-2009: Hold Cipla, target Rs 335: KR Choksey
30-10-2009: Hold Sun Pharma; target of Rs 1422: Sharekhan
29-10-2009: Dr Reddy's Labs an outperformer, target of Rs 1200: Karvy
16-10-2009: Lupin an outperformer, target of Rs 1560: Karvy
07-11-2009: Nifty ends higher; Suzlon, Jaiprakash gainFriday, November 6, 2009,10:17 [IST]
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
31-10-2009: Sensex loses 5.44 percent in week
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
31-10-2009: Sensex entrenched in consolidation zone, loses 5.44 percent in week
29-10-2009: Sell-off, weak global cues drag mkts downWednesday, October 28, 2009,10:18 [IST]
28-10-2009: Mkts bounce back on buying in RIL, L&T, WiproWednesday, October 28, 2009,10:18 [IST]
26-10-2009: Mkts end lower on sell off in IT, realty, bankingMonday, October 26, 2009,10:20 [IST]
26-10-2009: Mkts volatile; realty, banking, capital goods dipMonday, October 26, 2009,10:20 [IST]
23-10-2009: Mkts end lower on sell off in RIL and telecomFriday, October 23, 2009,10:12 [IST]
23-10-2009: Nifty shrugs off ve cues and hovers aroung 5kFriday, October 23, 2009,10:12 [IST]
23-10-2009: Nifty holds 5k mark on buying across sectorsFriday, October 23, 2009,10:12 [IST]
23-10-2009: Mkts bounce back on ve global cuesFriday, October 23, 2009,10:12 [IST]
18-10-2009: Sensex offers more than 100% return in Samvat 2065
16-10-2009: Mkts choppy; banking, power, IT, telecom upFriday, October 16, 2009,10:17 [IST]
15-10-2009: Mkts dip; selling in IT, FMGC, banking continuedThursday, October 15, 2009,10:14 [IST]
15-10-2009: Positive European cue ends Sensex above 17kWednesday, October 14, 2009,10:34 [IST]
12-10-2009: IIP, Anil's efforts push Sensex above17kMonday, October 12, 2009,10:57 [IST]
12-10-2009: Reliance, tech push Nifty to 5kMonday, October 12, 2009,10:57 [IST]
12-10-2009: Anil Ambani's effort to reconcile raises RILMonday, October 12, 2009,10:57 [IST]
10-11-2009: Emergency pills to maintain OTC drug status
08-11-2009: Recovery tempered by challenges
06-11-2009: Sensex: Hat-trick of gains
06-11-2009: Sensex ends above 16k mark; SBI, ITC gainThursday, November 5, 2009,10:23 [IST]
10-11-2009: Emergency pills to maintain OTC drug status
07-11-2009: Cholesterol drug sales set to double
03-11-2009: Nifty ends below 4550; Suzlon,Hindalco,DLF fall
03-11-2009: Nifty consolidates; Bajaj, Bharti upTuesday, November 3, 2009,10:15 [IST]
03-11-2009: EU seizes another generic package
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
23-10-2009: Dr.Reddy's Lab net profit rises 116.52 percent
09-11-2009: Generics Gateway
07-11-2009: HHS Orders Intravenous Antiviral Flu Medication To Help Patients Hospitalized With 2009 H1N1
07-11-2009: Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States
07-11-2009: Aurobindo drug gets US nod
08-11-2009: Recovery tempered by challenges
06-11-2009: NSE's stock options trade fails to mirror revival
28-10-2009: Lupin bets on Japanese elders
27-10-2009: Impressive Q2 results see Lupin net surge 38 per cent to Rs160 crore
